Thermo Fisher Scientific is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems.   Thermo Fisher’s single-use technologies are used for critical, sterile liquid-handling applications in the biopharmaceutical industry to help increase productivity and ensure quality in the production of biologic drugs.   “The demand for our bioproduction products and services continues t...